Combinatorial chemistry in drug discovery

被引:180
|
作者
Liu, Ruiwu [1 ,2 ]
Li, Xiaocen [1 ,2 ]
Lam, Kit S. [1 ,2 ,3 ]
机构
[1] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
ENCODED CHEMICAL LIBRARIES; SMALL-MOLECULE LIBRARIES; UNNATURAL AMINO-ACIDS; SOLID-PHASE SYNTHESIS; IN-VITRO; MACROCYCLIC PEPTIDES; BICYCLIC PEPTIDES; GENERAL-METHOD; INHIBITORS; DESIGN;
D O I
10.1016/j.cbpa.2017.03.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several combinatorial methods have been developed to create focused or diverse chemical libraries with a wide range of linear or macrocyclic chemical molecules: peptides, non-peptide oligomers, peptidomimetics, small-molecules, and natural product-like organic molecules. Each combinatorial approach has its own unique high-throughput screening and encoding strategy. In this article, we provide a brief overview of combinatorial chemistry in drug discovery with emphasis on recently developed new technologies for design, synthesis, screening and decoding of combinatorial library. Examples of successful application of combinatorial chemistry in hit discovery and lead optimization are given. The limitations and strengths of combinatorial chemistry are also briefly discussed. We are now in a better position to truly leverage the power of combinatorial technologies for the discovery and development of next-generation drugs.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 50 条